Поисковый запрос: (<.>S=ТИРАПАЗАМИН<.>) |
Общее количество найденных документов : 38
Показаны документы с 1 по 20
|
|
1.
| Delahoussaye Yvette M. Metabolism of tirapazamine by multiple reductases in the nucleus // Biochem. Pharmacol., 2001. Vol. 62, N 9.-С.1201-1209
|
2.
| Delahoussaye Yvette M. Metabolism of tirapazamine by multiple reductases in the nucleus // Biochem. Pharmacol., 2001. Vol. 62, N 9.-С.1201-1209
|
3.
| Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: The drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions // Biochemistry, 1999. Vol. 38, N 43.-С.14248-14255
|
4.
| Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: The drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions // Biochemistry, 1999. Vol. 38, N 43.-С.14248-14255
|
5.
| Patterson L.H. Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidizing free-radicals under anaerobic conditions // Biochem. Pharmacol., 2000. Vol. 60, N 12.-С.1933-1935
|
6.
| Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70
|
7.
| Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents // Cancer Res., 1999. Vol. 59, N 8.-С.1929-1934
|
8.
| Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70
|
9.
| Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70
|
10.
| A mass spectrometry study of tirapazamine and its metabolites: Insights into the mechanism of metabolic transformations and the characterization of reaction intermediates // J. Amer. Soc. Mass Spectrom., 2003. Vol. 14, N 8.-С.881-892
|
11.
| Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148
|
12.
| Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148
|
13.
| Еженедельный цисплатин+облучение по сравнению с цисплатином+тирапазамин+облучение при раке шейки матки, ограниченном малым тазом (IB2, IIA, IIB, IIIB и IVA стадии): рандомизированное исследование III фазы Gynecologic Oncology Group Study // J. Clin. Oncol. Рус. изд.. -Москва, 2014. Т. 8, N 2.-С.125
|
14.
| Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148
|
15.
| Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8
|
16.
| Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35
|
17.
| Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35
|
18.
| Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8
|
19.
| Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8
|
20.
| Tirapazamine is metabolized to its DNA-damaging radical by intranuclear enzymes // Cancer Res., 1998. Vol. 58, N 10.-С.2098-2101
|
&uf('+1W2226#',v2226), ?>
|
|